| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.0084 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.02 | 0.9 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | 0.021 | 0.9 |